The markets closed higher with the Dow climbing 94 points to 19,827 after the inauguration of President Donald Trump. Nasdaq gained 15 points to 5,555.
On the upside
Cartesian (Nasdaq: CRTN) reported strong growth in demand for its network transformation services.
Infinity Pharmaceuticals (Nasdaq: INFI) presented positive preclinical data for its oral immune-oncology development candidate IPI-549.
Stone Energy's (NYSE: SGY) purchase and sale agreement with TH Exploration was approved by a bankruptcy court.
On the downside
Bloomberg reported that the Federal Trade Commission would most likely not approve Walgreens Boots Alliance's (Nasdaq: WBA) proposed acquisition of Rite Aid (NYSE: RAD).
Citron Research said that TransDigm Group (NYSE: TDG) engaged in price gouging.
Uranium Resources (Nasdaq: URRE) closed its public offering of nearly 1.4 million common shares.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 index gained 7 points to 2,271. Bitcoin added $4 to $891.